Back

Efficacy and safety of prasugrel monotherapy compared with clopidogrel in Japanese patients with acute coronary syndrome after percutaneous coronary intervention

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Updates on dual antiplatelet therapy Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Eigo Nawata

National Cerebral & Cardiovascular Center, Suita (Japan)

5 More presentations in this session

Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation according to body mass index in patients undergoing drug-coated balloon angioplasty: insights from the REC-CAGEFREE II trial
Professor C. Gao (Hefei, CN)
Abstract
Presentation thumbnail
Efficacy and safety of short (≤6 months) versus prolonged (>6 months) dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis
Mr A. Gasca (Cali, CO)
Abstract
Presentation thumbnail
PRECISE-DAPT Score fails to predict clinically relevant bleeding in elderly patients with ACS
Doctor M. Santos Silva (Aveiro, PT)
Abstract
Presentation thumbnail
Organ-specific bleeding patterns under potent P2Y12 inhibition and triple therapy: mechanistic insights from a 24-month post-percutaneous coronary intervention cohort.
Mr J. Martin Diaz (Cordoba, ES)
Abstract
Presentation thumbnail
Ticagrelor-based dual antithrombotic therapy in anticoagulated patients undergoing PCI: a pooled analysis of two multicenter registries
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract

Access the full session

Session thumbnail
Updates on dual antiplatelet therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of prasugrel-based de-escalation versus conventional therapy after PCI in ACS patients
1 September 2025
thumbnail
Congress Presentation
Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study
1 September 2024
thumbnail
Congress Presentation
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
27 August 2022
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources